Cxbladder Resolve identifies those patients who are likely to have aggressive or more advanced bladder cancer. When used as part of the primary evaluation of haematuria and/or in conjunction with other Cxbladder tests (Triage, Detect), it assists clinicians by accurately identifying patients with a high probability of having high grade or late stage bladder cancer, for whom alternative or expedited treatment options may be warranted, or who can be prioritized for further investigation in high throughput settings.
